Functional role of BAALC in leukemogenesis

Leukemia

Volumn 26, Issue 3, 2012, Pages 532-536

  Heuser, M ^a,b   Berg, T ^a   Kuchenbauer, F ^a,c   Lai, C K ^a   Park, G ^a   Fung, S ^a   Lin, G ^a   Leung, M ^a   Krauter, J ^b   Ganser, A ^b   Humphries, R K ^b,d  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY HOSPITAL ULM   (Germany)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; GREEN FLUORESCENT PROTEIN; RETINOIC ACID; TRANSCRIPTION FACTOR HOXA9;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CELL PROLIFERATION; CHROMOSOME 8Q; CYTOGENETICS; CYTOTOXIC T LYMPHOCYTE; DRUG EFFECT; GENE EXPRESSION; GENE TRANSFER; HUMAN; LETTER; LEUKEMOGENESIS; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA; LEUKEMIA, MYELOID, ACUTE; MICE; NEOPLASM PROTEINS; TRETINOIN; TUMOR SUPPRESSOR PROTEINS;

EID: 84858000647     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2011.228     Document Type: Letter

References (12)

1. Baldus CD, Tanner SM, Ruppert AS, Whitman SP, Archer KJ, Marcucci G et al. BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study. Blood 2003; 102: 1613-1618. (Pubitemid 37022550)
2. Heuser M, Beutel G, Krauter J, Dohner K, von Neuhoff N, Schlegelberger B et al. High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics. Blood 2006; 108: 3898-3905. (Pubitemid 44864574)
3. Baldus CD, Thiede C, Soucek S, Bloomfield CD, Thiel E, Ehninger G. BAALC expression and FLT3 internal tandem duplication mutations in acute myeloid leukemia patients with normal cytogenetics: prognostic implications. J Clin Oncol 2006; 24: 790-797. (Pubitemid 46622046)
4. Langer C, Radmacher MD, Ruppert AS, Whitman SP, Paschka P, Mrozek K et al. High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study. Blood 2008; 111: 5371-5379.
5. Tanner SM, Austin JL, Leone G, Rush LJ, Plass C, Heinonen K et al. BAALC, the human member of a novel mammalian neuroectoderm gene lineage, is implicated in hematopoiesis and acute leukemia. Proc Natl Acad Sci USA 2001; 98: 13901-13906. (Pubitemid 33115996)
6. Langer C, Marcucci G, Holland KB, Radmacher MD, Maharry K, Paschka P et al. Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study. J Clin Oncol 2009; 27: 3198-3204.
7. Metzeler KH, Dufour A, Benthaus T, Hummel M, Sauerland MC, Heinecke A et al. ERG expression is an independent prognostic factor and allows refined risk stratification in cytogenetically normal acute myeloid leukemia: a comprehensive analysis of ERG, MN1, and BAALC transcript levels using oligonucleotide micro-arrays. J Clin Oncol 2009; 27: 5031-5038.
8. Heuser M, Argiropoulos B, Kuchenbauer F, Yung E, Piper J, Fung S et al. MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML. Blood 2007; 110: 1639-1647. (Pubitemid 47443982)
9. Carella C, Bonten J, Sirma S, Kranenburg TA, Terranova S, Klein- Geltink R et al. MN1 overexpression is an important step in the development of inv(16) AML. Leukemia 2007; 21: 1679-1690. (Pubitemid 47086758)
10. Heuser M, Sly LM, Argiropoulos B, Kuchenbauer F, Lai C, Weng A et al. Modeling the functional heterogeneity of leukemia stem cells: role of STAT5 in leukemia stem cell self-renewal. Blood 2009; 114: 3983-3993.
11. Baldus CD, Martus P, Burmeister T, Schwartz S, Gokbuget N, Bloomfield CD et al. Low ERG and BAALC expression identifies a new subgroup of adult acute T-lymphoblastic leukemia with a highly favorable outcome. J Clin Oncol 2007; 25: 3739-3745. (Pubitemid 47376607)
12. Kroon E, Krosl J, Thorsteinsdottir U, Baban S, Buchberg AM, Sauvageau G. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J 1998; 17: 3714-3725. (Pubitemid 28327389)